Molsidomine potentiates the protective activity of GYKI 52466, a non-NMDA antagonist, MK-801, a non-competitive NMDA antagonist, and riluzole against electroconvulsions in mice

By Tutka P.   Olszewski K.   Wozniak M.   Kleinrok Z.   Czuczwar S.J.   Wielosz M.  

European Neuropsychopharmacology, Vol. 12, Iss. 4, 2002-08 ,pp. : 321-326

Elsevier

Access to resources Recommend Favorite

Influence of LY 300164, an antagonist of AMPA/kainate receptors, on the anticonvulsant activity of clonazepam

By Borowicz K.K.   Luszczki J.   Szadkowski M.   Kleinrok Z.x.   Czuczwar S.x.J.  

European Journal of Pharmacology, Vol. 380, Iss. 2, 1999-09 ,pp. : 67-72

Elsevier

Access to resources Recommend Favorite

LY 300164, a novel antagonist of AMPA/kainate receptors, potentiates the anticonvulsive activity of antiepileptic drugs

By Czuczwar S.J.   Swiader M.   Kuzniar H.   Gasior M.   Kleinrok Z.  

European Journal of Pharmacology, Vol. 359, Iss. 2, 1998-10 ,pp. : 103-109

Elsevier

Access to resources Recommend Favorite

Influence of agents affecting voltage-dependent calcium channels and dantrolene on the anticonvulsant action of the AMPA/kainate receptor antagonist LY 300164 in mice

By Swiader M.   Borowicz K.K.   Porebiak J.   Kleinrok Z.   Czuczwar S.J.  

European Neuropsychopharmacology, Vol. 12, Iss. 4, 2002-08 ,pp. : 311-319

Elsevier

Access to resources Recommend Favorite

Non-NMDA receptor antagonist GYKI 52466 suppresses cortical afterdischarges in immature rats

By Kubova H.   Vilagi I.   Mikulecka A.   Mares P.  

European Journal of Pharmacology, Vol. 333, Iss. 1, 1997-08 ,pp. : 17-26

Elsevier

Access to resources Recommend Favorite